key: cord-1009490-ov5nbzrr
authors: Twu, Woan-Ing; Lee, Ji-Young; Kim, Heeyoung; Prasad, Vibhu; Cerikan, Berati; Haselmann, Uta; Tabata, Keisuke; Bartenschlager, Ralf
title: Contribution of autophagy machinery factors to HCV and SARS-CoV-2 replication organelle formation
date: 2021-11-10
journal: Cell Rep
DOI: 10.1016/j.celrep.2021.110049
sha: 28fd9cef95cf89741479d301ab6e04eab0a04d63
doc_id: 1009490
cord_uid: ov5nbzrr

Positive-strand RNA viruses replicate in close association with rearranged intracellular membranes. For hepatitis C virus (HCV) and SARS-CoV-2, these rearrangements comprise ER-derived double membrane vesicles (DMVs) serving as RNA replication sites. Cellular factors involved in DMV biogenesis are poorly defined. Here, we show that despite structural similarity of viral DMVs with autophagosomes, conventional macroautophagy is dispensable for HCV and SARS-CoV-2 replication. However, both viruses exploit factors involved in autophagosome formation, most notably class III phosphatidylinositol-3 kinase (PI3K). As revealed with a biosensor, PI3K is activated in cells infected with either virus to produce PI3P while kinase complex inhibition or depletion profoundly reduces replication and viral DMV formation. The PI3P-binding protein DFCP1 recruited to omegasomes in early steps of autophagosome formation, participates in replication and DMV formation of both viruses. These results indicate that phylogenetically unrelated HCV and SARS-CoV-2 exploit similar components of the autophagy machinery to create their replication organelles.

organelles can be grouped into two types: the invaginated vesicle/spherule type, and 28 the double-membrane vesicle (DMV) type (Paul and Bartenschlager, 2013) . 29

Virus-induced DMVs, ranging from ~100 to 300 nm in diameter, depending on the Table 1) . 157

To determine whether PIK-III affected HCV entry or RNA replication, we 158 transfected Huh7-derived cells with subgenomic replicons encoding for firefly 159 luciferase, enabling us to monitor post-entry steps. Transfected cells were treated 160 with any of the three drugs starting 4 h after transfection until cell harvest 20 h later. 161

We observed a dose-dependent inhibition of HCV replication by PIK-III with an EC50 162 very similar to the one determined with the infection system (~310nM; Figure S2C  163 and Table 1 ). Although this compound was ~15-fold less active in suppressing HCV 164

replication as compared to the PI4K inhibitor (Table 1) , these results suggest that 165 VPS34 activity is required for viral RNA replication.

VPS34 activity and determined the impact on HCV replication. We observed a consistent reduction of HCV replication in Beclin 1 depleted cells ( Figure S2D and 175 S2E), corroborating the important role of the class III PI3K complex for HCV RNA 176

replication. 177

To determine the role of PI3K for SARS-CoV-2 replication, we infected 178 A549/ACE2 cells with SARS-CoV-2 and treated the cells with PIK-III or the 179 nucleoside analogue Remdesivir that served as positive control ( Figure 2D and 180 Table 1 ). In the case of PIK-III, we observed a dose-dependent reduction of viral 181

replication with an EC50 of ~170 nM, which is at least ~250-fold below the CC50 182 value measured in this cell system (Table 1) . We also observed inhibition of 183 SARS-CoV-2 replication by PIK-III using Calu-3 cells, a commonly used human lung Daclatasvir and analyzed by confocal microscopy. Consistent with the data obtained 220 with HCV replicating cells ( Figure 3A and 3B), expression of NS3-5B increased the 221 number of GFP-DFCP1 puncta, indicating elevated PI3P production, which was 222 blunted when cells were treated with Daclatasvir ( Figure S4 ). This effect was specific 223 because the reduction of GFP-DFCP1 abundance by Daclatasvir was not observed 224 in cells expressing NS3-5B with NS5A containing the Daclatasvir-resistance 225 mutation Y93H ( Figure S4) . 226

With the aim to monitor PI3P production and subcellular distribution in the 227 context of SARS-CoV-2 replication, we infected Huh7-Lunet/T7/ACE2 cells and 228 cultured them in medium containing DMSO or 1 µM PIK-III. After 20 h, cells were 229 fixed and nucleocapsid and nsp3 were detected by immunofluorescence, along with 230 the PI3P sensor. Very similar to HCV, abundance of GFP-DFCP1 puncta was 231 to induce PI3P accumulation. 240 PI3P production is important for HCV and SARS-CoV-2 expression-induced 242

The results described so far indicate that inhibition of VPS34 by PIK-III blocks 244 Figure 4A ). In addition, transfection efficiency quantified by counting the number of 255 NS5A expressing cells ( Figure 4B ) and abundance of NS5A determined by 256 fluorescence microscopy were comparable between cells treated with DMSO or 257 PIK-III ( Figure S6B ). 258

Next, we analyzed the cells by transmission electron microscopy (TEM) to 259 determine the impact of PIK-III treatment on DMV formation. For this analysis we 260 46 PIK-III treated cells, which on a statistical basis includes at least 16 transfected 262 cells. We found that PIK-III treatment significantly reduced the number of DMVs 263 compared to DMSO-treated control cells ( Figure 4C and 4D) suggesting that PI3P 264 production is required for HCV NS3-5B induced DMV formation. 265

For SARS-CoV-2, we analyzed DMV formation in an analogous manner using 266 the HA-nsp3-4-V5 expression construct and 1 µM PIK-III, corresponding to ~10x 267 EC50. Also in this case, drug treatment did not affect cell viability, viral protein we investigated the colocalization of HA-nsp3 with LC3 and lysosomal-associated 277 membrane protein 1 (LAMP-1), markers for ERAD tuning and lysosomes, 278 respectively. We did not observe colocalization between HA-nsp3 and LC3 or 279 replication and DMV formation 284 DFCP1 is a PI3P effector protein that associates with omegasomes, the sites 285 from which phagophores form ( Figure 1A) . However, the exact function of the protein 286 Consistent with the earlier report, DFCP1 KD significantly reduced HCV replication 295 ( Figure 5C ). To study the effect of DFCP1 KD on SARS-CoV-2 replication, we used 296 A549/ACE2 cells. Also in these cells, KD efficiency was high and did not affect cell 297 viability ( Figure 5D and 5E, respectively). Notably, DFCP1 KD also drastically 298 reduced SARS-CoV-2 replication ( Figure 5F ). 299

To examine the role of DFCP1 in DMV formation, we employed our 300 expression-based systems to avoid confounding effects caused by replication 301 inhibition resulting from DFCP1 KD. For HCV, Huh7-Lunet/T7 cells were transfected 302 with either DFCP1 siRNA or the non-targeting control, followed by transfection with 303 the NS3-5B expression construct. In this case we used a variant of this construct 304 function ( Figure 6B ) (Schaller et al., 2007) . This variant was employed because we 306 analyzed the cells by correlative light and electron microscopy (CLEM) in order to 307 make sure that analyzed cells indeed had been transfected. Forty-eight hours after 308 transfection, cells were harvested and analyzed by western blotting and CLEM. KD 309 with either siRNA reduced DFCP1 to below our western blotting detection limit, while 310 it did not affect expression level of NS5A EGFP (note that the double band corresponds 311 to basal and hyperphosphorylated NS5A) ( Figure 6A ). Analysis of fixed cells by 312 CLEM revealed significant reduction of DMV abundance by KD with either siRNA as 313 compared to cells transfected with the control siRNA ( Figure 6B and 6C) . 314

In the case of SARS-CoV-2, we conducted the analogous experiments but using 315 a monocistronic expression construct encoding NeonGreen followed by 316 HA-nsp3-4-V5 ( Figure 6E ), with NeonGreen allowing the identification of transfected 317 cells and correlation with EM images and the HA-tag allowing the detection of 318 processed HA-nsp3. Consistent with the replication data, KD of DFCP1 also 319 impaired DMV formation induced by SARS-CoV-2 HA-nsp3-4-V5, which was not 320 due to effects of DFCP1 depletion on HA-nsp3-4-V5 abundance ( Figure 6D to 6F). 321

Taken together, our data suggest that DFCP1 is a critical host factor for efficient 322 replication of HCV and SARS-CoV-2. The most likely contribution of DFCP1 to 323 replication is to support the biogenesis of DMVs, which are the predominant 324 elements of the replication organelles and the sites of HCV and SARS-CoV-2 RNA 325

replication.

Here, we show that components involved in autophagosome formation, but not 329 conventional macroautophagy itself, are required for HCV and SARS-CoV-2 330 Consistently, in the case of SARS-CoV-2, we observed reduced viral replication in 367

Beclin 1 KD cells ( Figure S2F ) arguing that the class III PI3K complex, or 368 components thereof, is involved in HCV and SARS-CoV-2 replication. 369 highest non-cytotoxic concentration of PIK-III, residual viral replication was 371 detectable. One possible explanation for this observation is the use of alternative 372 sources for PI3P. In addition to PI3K, PI3P can be generated by phosphatases such 373 as phosphatidylinositol-4-phosphatase or 5-phosphatase from other 374 phosphoinositides, thus compensating for loss of VPS34 function. Alternatively, 375 even at highest PIK-III concentrations, we still observed few GFP-DFCP1 puncta, 376

indicating that very low amounts of PI3P might suffice to promote replication of these 377 two viruses. In any case, we note that suppression of viral replication by VPS34 378 inhibition has also been reported for tombusviruses, including cucumber leaf spot 379 virus, turnip crinkle virus, and red clover necrotic mosaic virus that create replication host-targeting broad-spectrum antivirals that are urgently needed for better 460 preparedness against future pandemics. 461

Our study is based on the use of cell lines that, although widely used to study HCV Table 1 

EC50 and CC50 values were calculated using data sets reported in Figure 2A , D and 658 Figure S2C . 

Total RNA was extracted from SARS-CoV-2-infected cells using NucleoSpin 801 RNA extraction kit (Machery-Nagel) following manufacturer's protocol. Reverse 802 transcription (RT) reaction for cDNA synthesis was performed using the high 803 capacity cDNA RT kit (ThermoScientific). Each cDNA was diluted 1:5 in nuclease 804 free H 2 O and qPCR was performed using iTaq Universal SYBR green mastermix 805 (Bio-Rad). Primers for qPCR were designed using Primer3 for SARS-CoV-2-ORF1 806 CaCl 2 , post-fixed with 2% OsO 4 and then treated with 0.5% uranyl acetate. Cells 916 were dehydrated and embedded into Epon resin. After polymerization of the 917 embedded samples, 70 nm thick slices were generated using a microtome. Images 918 were obtained with a JEOL JEM1400 (JEOL) microscope and processed using the 919 ImageJ software package. DMV number and size were quantified by manually 920 mapping the DMVs using ImageJ. 921 and the differential interference contrast (DIC) signal of these cells were acquired for 929 correlation to electron microscopy images. Cells were then fixed and processed for 930 TEM as described above. GFP-positive cells were located in electron microscopy 931 using the grid coordinates and DIC signals, and their images were acquired and 932 analyzed as described above for TEM. autophagy-related gene decreases the production of infectious hepatitis C virus particles. Autophagy

In brief, cells were fixed with 4% paraformaldehyde (PFA) at room

Three-dimensional architecture and biogenesis of 1118 membrane structures associated with hepatitis C virus replication

Analysis of hepatitis C virus superinfection exclusion by using novel 1121 fluorochrome gene-tagged viral genomes

Severe acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to 1124 proteasome-independent inhibition of M-calpain

Electroporation in 'intracellular' buffer 1159 increases cell survival

Autophagy in HCV infection: keeping fat and inflammation at bay

WHO coronavirus disease (COVID-19) dashboard